MetaCap

Climb Bio (CLYM) News

NASDAQ: CLYMHealth CareBiotechnology: Pharmaceutical PreparationsUSD

9.19-0.09 (-0.97%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CLYM news summary

We found 9 recent headlines mentioning Climb Bio (CLYM): 0 in the past week and 7 in the past 30 days, most often from GlobeNewswire, Investing.com, Nasdaq. For price context, CLYM is down 0.97% at $9.19. The most recent story, "Wedbush keeps Climb Bio on Best Ideas List, raises price target", was published by Investing.com on Nov 6, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Climb Bio headlines

Stocks mentioned alongside CLYM

Compare CLYM